Medicare’s AI Push Snarls Patients and Doctors in Errors and Delays

Why It Matters

The pilot adds costly administrative friction for seniors and providers, and could become a template for nationwide AI‑based prior authorizations, reshaping Medicare’s cost structure and patient access.

Key Takeaways

• WISeR pilot adds AI prior authorizations for 13 Medicare services.
• Oklahoma patients report extra trips and delayed epidurals due to approvals.
• Providers see 6‑8 week payment delays and AI‑driven denial errors.
• 88% of AI‑approved cases receive immediate yes, but backlogs persist.
• Expansion risk: pilot could extend prior auth to most Medicare procedures.

Pulse Analysis

The Medicare administration’s WISeR initiative reflects a broader push to harness artificial intelligence for cost containment. By targeting services flagged for potential fraud—epidural injections, kyphoplasties, and skin substitutes—the program aims to trim waste while preserving necessary care. AI algorithms can instantly scan clinical data, delivering approvals within the promised 72‑hour window for the majority of straightforward cases, a speed that private insurers have already begun to emulate. This technological shift aligns with a growing industry trend where 84% of commercial insurers now employ AI tools for claims processing.

However, the pilot’s rapid deployment has exposed significant operational flaws. Physicians in the six participating states report that the new workflow forces additional paperwork, duplicate appointments, and prolonged payment cycles, with some providers waiting six to eight weeks for reimbursement. Errors attributed to AI “hallucinations”—where the system misinterprets clinical notes—have led to inappropriate denials, prompting appeals that further strain Medicare’s administrative budget. Real‑world anecdotes, such as Bill Curry’s extra travel for a simple epidural, illustrate how the model can translate into tangible patient inconvenience and higher out‑of‑pocket costs.

Looking ahead, WISeR’s performance will likely influence policy decisions about scaling AI‑driven prior authorizations across Medicare. If the pilot demonstrates measurable savings without compromising care quality, lawmakers may broaden the list of scrutinized procedures, potentially extending the model to the majority of services. Critics warn that such expansion could shift financial burdens onto providers and patients, eroding access for vulnerable seniors. Stakeholders therefore face a trade‑off between administrative efficiency and the risk of amplifying red tape, making transparent evaluation and iterative refinement essential for the program’s long‑term viability.